Skip to content
Open access

Placental small extracellular vesicles and cardiac mitochondrial dynamics in preeclampsia

Sep 2026 · Cell Death & Disease · 0 citations

Abstract

Preeclampsia is a hypertensive disorder of pregnancy that confers a markedly increased risk of maternal cardiovascular disease, yet the mechanisms linking placental pathology to maternal cardiac dysfunction remain poorly understood. Placental hypoxia is a central feature of early-onset preeclampsia (E-PE) and promotes the systemic release of placental debris, including bioactive extracellular vesicles, emerging mediators of placenta-to-maternal communication capable of modulating maternal physiology. Using a placenta-specific Phd2 conditional knockout mouse model that recapitulates human E-PE, we identified maternal cardiac structural and functional abnormalities accompanied by pronounced mitochondrial ultrastructural disruption and enhanced mitochondrial fission in the left ventricular myocardium. Hence, we next investigated whether placenta-derived small extracellular vesicles (P-sEVs) contribute to maternal cardiac mitochondrial remodeling in preeclampsia. Circulating P-sEVs isolated from both murine and human preeclamptic pregnancies induced DRP1-dependent mitochondrial fragmentation and increased endoplasmic reticulum-mitochondria tethering in human cardiomyocytes in vitro. Exposure to preeclamptic P-sEVs reduced cellular ATP levels and impaired mitochondrial membrane potential without affecting cardiomyocyte viability, consistent with impaired mitochondrial bioenergetics. Lipidomic profiling by LC-MS/MS revealed enrichment of bioactive ceramide and sphingomyelin species in preeclamptic P-sEVs, which were sufficient to recapitulate mitochondrial remodeling in cardiomyocytes. Disrupting sphingolipid metabolism in hypoxia-exposed H9-cytotrophoblasts attenuated the capacity of their sEVs to induce DRP1-mitochondrial colocalization in recipient human cardiomyocytes. Importantly, pharmacological inhibition of placental HIF-1 signaling attenuated the ability of preeclamptic P-sEVs to disrupt cardiomyocyte mitochondrial dynamics. Together, these findings identify maternal circulating placental sEVs as previously unrecognized contributors to cardiomyocyte mitochondrial homeostasis and define a placenta-heart signaling axis through which placental hypoxic stress drives maternal cardiac mitochondrial remodeling in preeclampsia.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.